- Home
- ORRF vs XNCR Comparison
ORRF vs XNCR Comparison
Compare ORRF & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORRF
- XNCR
- Stock Information
- Founded
- ORRF 1919
- XNCR 1997
- Country
- ORRF United States
- XNCR United States
- Employees
- ORRF N/A
- XNCR N/A
- Industry
- ORRF Major Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ORRF Finance
- XNCR Health Care
- Exchange
- ORRF Nasdaq
- XNCR Nasdaq
- Market Cap
- ORRF 608.7M
- XNCR 565.1M
- IPO Year
- ORRF N/A
- XNCR 2013
- Fundamental
- Price
- ORRF $34.06
- XNCR $9.14
- Analyst Decision
- ORRF Buy
- XNCR Buy
- Analyst Count
- ORRF 2
- XNCR 7
- Target Price
- ORRF $39.00
- XNCR $27.50
- AVG Volume (30 Days)
- ORRF 155.9K
- XNCR 688.3K
- Earning Date
- ORRF 07-22-2025
- XNCR 08-04-2025
- Dividend Yield
- ORRF 3.10%
- XNCR N/A
- EPS Growth
- ORRF N/A
- XNCR N/A
- EPS
- ORRF 1.84
- XNCR N/A
- Revenue
- ORRF $203,869,000.00
- XNCR $127,228,000.00
- Revenue This Year
- ORRF $15.80
- XNCR N/A
- Revenue Next Year
- ORRF $3.45
- XNCR $28.84
- P/E Ratio
- ORRF $18.20
- XNCR N/A
- Revenue Growth
- ORRF 56.29
- XNCR N/A
- 52 Week Low
- ORRF $25.57
- XNCR $7.16
- 52 Week High
- ORRF $41.99
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ORRF 63.56
- XNCR 56.06
- Support Level
- ORRF $33.45
- XNCR $8.90
- Resistance Level
- ORRF $34.05
- XNCR $9.39
- Average True Range (ATR)
- ORRF 0.59
- XNCR 0.47
- MACD
- ORRF -0.05
- XNCR 0.08
- Stochastic Oscillator
- ORRF 62.15
- XNCR 80.97
About ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.